However, HSPGs content is deteriorated in the brain tissue of GBM patients: high expression of glypican-1 in GBM patients who received adjuvant radiochemotherapy significantly correlates with their survival and predicts poor prognosis (46). The gene discussed is GPC1; the disease is glioblastoma.